Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial.
Lend K, van Vollenhoven RF, Lampa J, Lund Hetland M, Haavardsholm EA, Nordström D, Nurmohamed M, Gudbjornsson B, Rudin A, Østergaard M, Uhlig T, Grondal G, Hørslev-Petersen K, Heiberg MS, Sokka-Isler T, Koopman FA, Twisk JWR, van der Horst-Bruinsma I. Lend K, et al. Among authors: van vollenhoven rf, van der horst bruinsma i. Lancet Rheumatol. 2022 Oct;4(10):e688-e698. doi: 10.1016/S2665-9913(22)00186-2. Epub 2022 Aug 23. Lancet Rheumatol. 2022. PMID: 38265967 Clinical Trial.
Systemic lupus erythematosus and pregnancy.
Druzin ML, Van Vollenhoven RF. Druzin ML, et al. Among authors: van vollenhoven rf. Ann Med Interne (Paris). 1996;147(4):265-73. Ann Med Interne (Paris). 1996. PMID: 8952746 Review.
Severe rheumatoid arthritis.
van Vollenhoven RF. van Vollenhoven RF. J Rheumatol. 1999 Jan;26(1):197. J Rheumatol. 1999. PMID: 9918263 No abstract available.
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression.
Rönnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF. Rönnelid J, et al. Among authors: van vollenhoven rf. Ann Rheum Dis. 2005 Dec;64(12):1744-9. doi: 10.1136/ard.2004.033571. Epub 2005 Apr 20. Ann Rheum Dis. 2005. PMID: 15843452 Free PMC article.
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.
Hueber W, Tomooka BH, Batliwalla F, Li W, Monach PA, Tibshirani RJ, Van Vollenhoven RF, Lampa J, Saito K, Tanaka Y, Genovese MC, Klareskog L, Gregersen PK, Robinson WH. Hueber W, et al. Among authors: van vollenhoven rf. Arthritis Res Ther. 2009;11(3):R76. doi: 10.1186/ar2706. Epub 2009 May 21. Arthritis Res Ther. 2009. PMID: 19460157 Free PMC article.
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, Zickert A, Theander J, Thörner A, Hellström H, Teleman A, Dackhammar C, Akre F, Forslind K, Ljung L, Oding R, Chatzidionysiou A, Wörnert M, Bratt J. van Vollenhoven RF, et al. Lancet. 2009 Aug 8;374(9688):459-66. doi: 10.1016/S0140-6736(09)60944-2. Lancet. 2009. PMID: 19665644 Clinical Trial.
435 results